BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,420
-460 (-3.31%)
At close: Apr 2, 2026

BIO-FD&C Statistics

Total Valuation

BIO-FD&C has a market cap or net worth of KRW 116.70 billion. The enterprise value is 64.29 billion.

Market Cap116.70B
Enterprise Value 64.29B

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

BIO-FD&C has 8.70 million shares outstanding. The number of shares has increased by 0.13% in one year.

Current Share Class 8.70M
Shares Outstanding 8.70M
Shares Change (YoY) +0.13%
Shares Change (QoQ) +0.31%
Owned by Insiders (%) 31.22%
Owned by Institutions (%) 0.21%
Float 5.19M

Valuation Ratios

The trailing PE ratio is 17.18.

PE Ratio 17.18
Forward PE n/a
PS Ratio 6.08
PB Ratio 1.67
P/TBV Ratio 1.68
P/FCF Ratio 18.51
P/OCF Ratio 16.03
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.49, with an EV/FCF ratio of 10.20.

EV / Earnings 9.64
EV / Sales 3.35
EV / EBITDA 8.49
EV / EBIT 10.28
EV / FCF 10.20

Financial Position

The company has a current ratio of 17.06, with a Debt / Equity ratio of 0.01.

Current Ratio 17.06
Quick Ratio 16.23
Debt / Equity 0.01
Debt / EBITDA 0.05
Debt / FCF 0.06
Interest Coverage 160.56

Financial Efficiency

Return on equity (ROE) is 10.03% and return on invested capital (ROIC) is 29.95%.

Return on Equity (ROE) 10.03%
Return on Assets (ROA) 5.55%
Return on Invested Capital (ROIC) 29.95%
Return on Capital Employed (ROCE) 8.93%
Weighted Average Cost of Capital (WACC) 7.18%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.27
Inventory Turnover 3.20

Taxes

In the past 12 months, BIO-FD&C has paid 1.28 billion in taxes.

Income Tax 1.28B
Effective Tax Rate 16.15%

Stock Price Statistics

The stock price has increased by +1.74% in the last 52 weeks. The beta is 0.53, so BIO-FD&C's price volatility has been lower than the market average.

Beta (5Y) 0.53
52-Week Price Change +1.74%
50-Day Moving Average 14,733.20
200-Day Moving Average 16,976.70
Relative Strength Index (RSI) 40.62
Average Volume (20 Days) 19,072

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, BIO-FD&C had revenue of KRW 19.18 billion and earned 6.67 billion in profits. Earnings per share was 781.00.

Revenue19.18B
Gross Profit 12.87B
Operating Income 6.25B
Pretax Income 7.95B
Net Income 6.67B
EBITDA 7.57B
EBIT 6.25B
Earnings Per Share (EPS) 781.00
Full Income Statement

Balance Sheet

The company has 52.76 billion in cash and 351.94 million in debt, with a net cash position of 52.41 billion or 6,026.70 per share.

Cash & Cash Equivalents 52.76B
Total Debt 351.94M
Net Cash 52.41B
Net Cash Per Share 6,026.70
Equity (Book Value) 69.80B
Book Value Per Share 8,200.53
Working Capital 54.75B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.28 billion and capital expenditures -974.37 million, giving a free cash flow of 6.30 billion.

Operating Cash Flow 7.28B
Capital Expenditures -974.37M
Depreciation & Amortization 1.32B
Net Borrowing -1.20B
Free Cash Flow 6.30B
FCF Per Share 724.99
Full Cash Flow Statement

Margins

Gross margin is 67.13%, with operating and profit margins of 32.60% and 34.76%.

Gross Margin 67.13%
Operating Margin 32.60%
Pretax Margin 41.45%
Profit Margin 34.76%
EBITDA Margin 39.49%
EBIT Margin 32.60%
FCF Margin 32.87%

Dividends & Yields

BIO-FD&C does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.13%
Shareholder Yield -0.13%
Earnings Yield 5.71%
FCF Yield 5.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

BIO-FD&C has an Altman Z-Score of 25.42 and a Piotroski F-Score of 6.

Altman Z-Score 25.42
Piotroski F-Score 6